Format

Send to

Choose Destination
Ann Rheum Dis. 2015 May;74(5):e34. doi: 10.1136/annrheumdis-2015-207419. Epub 2015 Mar 9.

Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr Boers.

Author information

1
University of Montreal Hospital Research Center (CRCHUM), Montreal, Quebec, Canada.
2
Department of Medicine, Dermatology Service, St-Luc Hospital, Montreal, Quebec, Canada.
3
Sacré-Coeur Hospital of Montreal, University of Montreal, Montreal, Quebec, Canada.
4
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
5
Division of Rheumatology, University of Alberta, Edmonton, Alberta, Canada.
6
Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.
7
Division of Rheumatology, Department of Medicine, Western University of Canada, St. Joseph's Health Care, London, Ontario, Canada.
8
Lynde Dermatology, Markham, Ontario, Canada.
9
Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
10
Department of Medicine, Centre de Recherche du CHU de Québec, Laval University, Quebec City, Quebec, Canada.
11
Innovaderm Research, Montreal, Quebec, Canada.
12
Department of Medicine, Rheumatic Disease Unit, Centre Hospitalier de l'Université de Montréal (CHUM) and Institut de Rhumatologie de Montréal, Montreal, Quebec, Canada.

KEYWORDS:

Cardiovascular Disease; Rheumatoid Arthritis; Treatment

PMID:
25755140
DOI:
10.1136/annrheumdis-2015-207419
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center